Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1. (Q40018845)

16 September 2017

title

Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1. (English)

1 reference

16 September 2017

1 reference

Anna V Hoekstra

1

1 reference

16 September 2017

Erin C Ward

2

1 reference

16 September 2017

Jennifer L Hardt

3

1 reference

16 September 2017

John R Lurain

4

1 reference

16 September 2017

Diljeet K Singh

5

1 reference

16 September 2017

Barbara M Buttin

6

1 reference

16 September 2017

Julian C Schink

7

1 reference

16 September 2017

J Julie Kim

8

1 reference

16 September 2017

language of work or name

English

0 references

publication date

29 January 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

108

1 reference

16 September 2017

issue

3

1 reference

16 September 2017

page(s)

609-618

1 reference

16 September 2017

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Prognostic parameters of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

PTEN mutations and evolving concepts in endometrial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

PTEN controls tumor-induced angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Biologic targets for therapeutic intervention in endometrioid endometrial adenocarcinoma and malignant mixed müllerian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

AKT involvement in cisplatin chemoresistance of human uterine cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Potentiation of chemosensitivity in multidrug-resistant human leukemia CEM cells by inhibition of DNA-dependent protein kinase using wortmannin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Practicalities of drugging the phosphatidylinositol-3-kinase/Akt cell survival signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

FOXO1A differentially regulates genes of decidualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Regulation of cell death protease caspase-9 by phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

9-hydroxyellipticine and derivatives as chemotherapy agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Forkhead transcription factors contribute to execution of the mitotic programme in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Progestins regulate the expression and activity of the forkhead transcription factor FOXO1 in differentiating human endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Novel polyphenol molecule isolated from licorice root (Glycrrhiza glabra) induces apoptosis, G2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.007

10.1016/J.YGYNO.2007.11.007

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference